| | | | | | | | Welcome to Editors' (re)View, a feature where the Pharma Manufacturing editors handpick notable pharma world happenings that deserve some extra consideration. See what you may have missed this week in pharma. |
|
|
|
| |
| | |
|
|
| | | | | In a play to better its cardio health offerings, J&J will pick up a medical device maker active in CAD and PAD. |
|
|
| The potential $1.4 billion deal gives Merck KGaA access to Caris' proprietary technologies to develop novel cancer ADCs. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Advanced chemical indicators give you the peace of mind that comes from reliable insights into your supply chains. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
